A039840 Stock Overview
DIO Corporation manufactures and sells dental implants in South Korea.
Price History & Performance
|Historical stock prices|
|Current Share Price||₩31,700.00|
|52 Week High||₩55,000.00|
|52 Week Low||₩29,900.00|
|1 Month Change||-11.45%|
|3 Month Change||2.26%|
|1 Year Change||-16.03%|
|3 Year Change||-14.32%|
|5 Year Change||-12.79%|
|Change since IPO||736.41%|
Recent News & Updates
|A039840||KR Medical Equipment||KR Market|
Return vs Industry: A039840 underperformed the KR Medical Equipment industry which returned -4.7% over the past year.
Return vs Market: A039840 underperformed the KR Market which returned -14.3% over the past year.
|A039840 Average Weekly Movement||5.2%|
|Medical Equipment Industry Average Movement||5.6%|
|Market Average Movement||5.4%|
|10% most volatile stocks in KR Market||10.2%|
|10% least volatile stocks in KR Market||3.1%|
Stable Share Price: A039840 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: A039840's weekly volatility (5%) has been stable over the past year.
About the Company
DIO Corporation manufactures and sells dental implants in South Korea. It offers implant systems, which include UFII int. submerged and no-submerged systems, FTN external systems, protem mini systems, UV active and activators, and instrument kits.
DIO Fundamentals Summary
|A039840 fundamental statistics|
Is A039840 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A039840 income statement (TTM)|
|Cost of Revenue||₩42.49b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||1.91k|
|Net Profit Margin||18.83%|
How did A039840 perform over the long term?See historical performance and comparison
Is DIO undervalued compared to its fair value and its price relative to the market?
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: A039840 (₩31700) is trading above our estimate of fair value (₩6107.38)
Significantly Below Fair Value: A039840 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A039840 is poor value based on its Price-To-Earnings Ratio (16.6x) compared to the KR Medical Equipment industry average (13.6x).
PE vs Market: A039840 is poor value based on its Price-To-Earnings Ratio (16.6x) compared to the KR market (14.1x).
Price to Earnings Growth Ratio
PEG Ratio: A039840 is good value based on its PEG Ratio (0.7x)
Price to Book Ratio
PB vs Industry: A039840's Price-To-Book Ratio (2.5x) is in line with the KR Medical Equipment industry average.
How is DIO forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A039840's forecast earnings growth (23.4% per year) is above the savings rate (3.5%).
Earnings vs Market: A039840's earnings (23.4% per year) are forecast to grow faster than the KR market (14.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A039840's revenue (19.5% per year) is forecast to grow faster than the KR market (9.6% per year).
High Growth Revenue: A039840's revenue (19.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A039840's Return on Equity is forecast to be low in 3 years time (19.3%).
How has DIO performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A039840 has high quality earnings.
Growing Profit Margin: A039840's current net profit margins (18.8%) are higher than last year (9.3%).
Past Earnings Growth Analysis
Earnings Trend: A039840's earnings have grown by 7.6% per year over the past 5 years.
Accelerating Growth: A039840's earnings growth over the past year (153.3%) exceeds its 5-year average (7.6% per year).
Earnings vs Industry: A039840 earnings growth over the past year (153.3%) exceeded the Medical Equipment industry 15.1%.
Return on Equity
High ROE: A039840's Return on Equity (15%) is considered low.
How is DIO's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A039840's short term assets (₩201.2B) exceed its short term liabilities (₩140.5B).
Long Term Liabilities: A039840's short term assets (₩201.2B) exceed its long term liabilities (₩20.1B).
Debt to Equity History and Analysis
Debt Level: A039840's net debt to equity ratio (37.9%) is considered satisfactory.
Reducing Debt: A039840's debt to equity ratio has increased from 8.9% to 56.5% over the past 5 years.
Debt Coverage: A039840's debt is not well covered by operating cash flow (5.9%).
Interest Coverage: A039840's interest payments on its debt are well covered by EBIT (8.9x coverage).
What is DIO current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate A039840's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A039840's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if A039840's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A039840's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: A039840 is not paying a notable dividend for the KR market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A039840 has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Jin-Cheol Kim (69 yo)
Mr. Jin-Cheol Kim serves as Chairperson of the Board and Chief Executive Officer of DIO Corporation. Mr. Kim serves as Chief Executive Officer of Dong Seo Inc. He graduated at yungpook National University....
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
DIO Corporation's employee growth, exchange listings and data sources
- Name: DIO Corporation
- Ticker: A039840
- Exchange: KOSDAQ
- Founded: 1988
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: ₩469.386b
- Shares outstanding: 14.81m
- Website: https://www.dio.co.kr
Number of Employees
- DIO Corporation
- 66, Centum seo-ro
- South Korea
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/24 00:00|
|End of Day Share Price||2022/05/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.